InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Vazzano Joseph Walter, Chief Financial Officer. Director active across 2 companies, notably Avenue Therapeutics, INC.. In total, 5 filings have been logged. Total volume traded: €20k. The latest transaction was disclosed on 14 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
0200,000 shares0
Common stock
SEC:0001493152-22-006976:0·
0100,505 shares0
Common Stock
SEC:0001104659-21-151771·
0100,505 shares0
Common Stock
SEC:0001104659-21-151771:0·
€9,8137,160 shares@ €1.3706100.0% of flow
Common Stock
SEC:0001104659-21-115916·
€9,8137,160 shares@ €1.37060.45% mcap50.0% of flow
Common Stock
SEC:0001104659-21-115916:0·
5 of 5 declarations
About Vazzano Joseph Walter
Joseph Walter Vazzano serves as the Chief Financial Officer at Avenue Therapeutics, Inc. and Abeona Therapeutics Inc. In this role, he is responsible for managing the finances of both companies, which specialize in developing treatments for rare diseases. Joseph plays a key role in financial planning and funding strategy. His financial expertise is essential for ensuring the growth and sustainability of the companies.
